25.01.2013 Views

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

Cancer Immune Therapy Edited by G. Stuhler and P. Walden ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

158 8 Interleukin-10 in <strong>Cancer</strong> Immunity<br />

Tab. 8.2 Effects of IL-10 on immune cells<br />

Cell population Suppression Induction Reference<br />

Monocytes/<br />

macrophages<br />

TNF-a, IL-1, -8, -12 production;<br />

antigen presentation<br />

present the major target of IL-10. This is partly due to different levels of IL-10Ra expression<br />

among the IL-10-responsive cell populations.<br />

8.3.1<br />

Effectson Myeloid Antigen-Presenting Cells(APC)<br />

IL-1RA production;<br />

phagocytosis<br />

42±44, 47±51<br />

DCs development; antigen presentation 39, 40, 141<br />

T cells IL-2, -4, -5, IFN-g production;<br />

proliferation<br />

NK cells cytotoxic activity;<br />

IFN-g,TNF-aproduction B cells proliferation; differentiation<br />

58, 59, 142,<br />

143<br />

18, 69<br />

70, 71<br />

Neutrophils TNF-a, IL-1b, IL-8 production IL-1RA production 74, 75<br />

Eosinophils TNF-a, GM-CSF, IL-8 production 77<br />

Mast cells TNF-a, GM-CSF, NO production growth; histamine<br />

liberation<br />

78, 79, 144<br />

Blood monocytes are very sensitive to the presence of IL-10. These cells are not a finally<br />

differentiated population. After their 48 h residence in the circulation they emigrate<br />

into the stromal tissues where they, depending on the micromilieu, develop<br />

into more specialized cell populations, into either macrophages or type 1 dendritic<br />

cells (DC1) [38]. IL-10 is able to prevent monocyte differentiation into DC1, which are<br />

the most important APCs, especially for primary immune responses [39±41]. During<br />

DC1 development the influence of IL-10 on these cells decreases. This is associated<br />

with a decrease of cellular IL-10Ra expression (R. Sabat, unpublished). In contrast,<br />

IL-10 supports monocyte maturation to macrophages <strong>and</strong> the sensitivity of macrophages<br />

towards IL-10 is comparable to that of monocytes ([40] <strong>and</strong> R. Sabat, unpublished).<br />

The functions of monocytes <strong>and</strong> macrophages which are regulated <strong>by</strong> IL-10<br />

can be divided into three groups: (1) production of soluble immunomediators, (2)<br />

antigen presentation <strong>and</strong> (3) phagocytosis. In general, IL-10 inhibits all those activities<br />

that favor the inflammatory or specific cellular immune response <strong>and</strong> enhances<br />

those activities that are associated with induction of tolerance in specific immunity as<br />

well as with scavenger function. More concretely, IL-10 inhibits the production of<br />

pro-inflammatory mediators <strong>by</strong> monocytes <strong>and</strong> macrophages, such as endotoxin- <strong>and</strong><br />

IFN-g-induced release of IL-1b, IL-6, IL-8, granulocyte colony stimulating factor<br />

(CSF), granulocyte macrophage colony stimulating factor (GM-CSF) <strong>and</strong> tumor necrosis<br />

factor (TNF)-a [42, 43]. In addition, it enhances the production of anti-inflammatory<br />

mediators like IL-1RA <strong>and</strong> soluble TNF-a receptors [44±46]. Moreover, IL-10

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!